Distal Pancreatectomy
Distal Pancreatectomy - Related Videos
07:33
Robotic Spleen-Preserving Distal Pancreatectomy: The Warshaw and Kimura Techniques
0 Views •
Cited by 2 •
2024
Here, we present a step-by-step protocol of robotic spleen preserving distal pancreatectomy, with and without preserving the splenic vessels (i.e., the Kimura and Warshaw techniques, respectively).
10:38
DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens
0 Views •
Cited by 10 •
2020
The current study highlights a standardized approach to the macroscopic assessment of distal pancreatectomy specimens for pancreatic ductal adenocarcinoma, with special emphasis on the measurement of pancreatic dimensions and those of other organs, inking of margins, measurement of tumor size and proximity to margins, lymph node sampling and block selection.
13:56
Robot Assisted Distal Pancreatectomy with Celiac Axis Resection (DP-CAR) for Pancreatic Cancer: Surgical Planning and Technique
0 Views •
Cited by 3 •
2021
We present our operative approach to robot assisted distal pancreatectomy, splenectomy, and celiac axis resection (DP-CAR), demonstrating that the procedure is safe and feasible with proper planning, patient selection, and surgeon experience.
10:58
Application of End-to-end Anastomosis in Robotic Central Pancreatectomy
0 Views •
Cited by 8 •
2018
The robotic central pancreatectomy with end-to-end anastomosis is feasible and safe for tumor in the pancreatic neck and proximal portion of pancreatic body. The operative techniques of this operation are presented.
10:34
Robotic Central Pancreatectomy with Roux-en-Y Pancreaticojejunostomy
0 Views •
Cited by 7 •
2021
Robotic central pancreatectomy may be used in selected patients in experienced centers. This protocol presents all steps and the feasibility of a robotic central pancreatectomy with Roux-en-Y pancreaticojejunostomy in a 16-year-old adolescent patient.
FAQs
After the pancreas is divided beyond the tumor, surgeons must control the remaining pancreatic tissue to limit leakage of digestive enzymes. This technical step directly relates to postoperative safety because leakage can contribute to complications. Cancer research therefore examines how remnant management affects outcomes, alongside broader evaluations of postoperative complications and pancreatic function.
The procedure offers potentially curative local treatment when disease remains resectable, meaning the tumor can be removed surgically within the treatment plan described. Its value therefore depends on whether local removal is feasible, rather than applying equally to every pancreatic or nearby tumor. Surgical findings can also guide prognosis and later treatment planning.
Regional lymph nodes may be removed for pathological examination, allowing investigators and clinicians to evaluate disease involvement beyond the primary tumor. Those findings contribute to cancer staging, which helps describe the extent of disease and inform prognosis. In research, node findings can also be considered alongside molecular results and recurrence patterns when studying treatment outcomes.
Resected tumor and surrounding tissue provide specimens for molecular analysis. Researchers can use this material to investigate tumor characteristics and relate molecular findings to surgical observations, pathological staging, prognosis, or later recurrence. This connection makes the operation relevant not only as local treatment, but also as a source of biological information for studying systemic and targeted therapies.
The operation removes the pancreatic body and tail, with spleen removal in some cases. Surgeons divide the pancreas beyond the tumor, control the pancreatic remnant to limit digestive-enzyme leakage, and may remove regional lymph nodes for pathological examination and staging. These steps generate both the therapeutic result and the tissue and clinical data used in cancer studies.
Studies commonly monitor postoperative complications and pancreatic function after the operation. These measures help researchers assess the consequences of removing part of the pancreas and managing its remnant. Follow-up may also examine recurrence patterns, because disease return provides important information about treatment effectiveness, prognosis, and the relationship between local surgery and broader cancer behavior.
Surgical findings, pathological staging, molecular analysis, complications, pancreatic function, and recurrence patterns can be evaluated together to improve understanding of disease and outcome. In the research setting, these data help inform prognosis and support the design of systemic or targeted therapies. The procedure therefore connects local tumor removal with investigation of treatments acting beyond the surgical site.